Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy - Ni, Jianxin; Yan, Fengqi; Qin, Weijun; Yu, Lei; Zhang, Geng; Liu, Fei; Yang, Xiaojian; Yang, Bo; Hao, Chunlin; Wang, Teng; Liu, Pengfei; Yuan, Jianlin; et al. (Scientific reports, 2019)
Keywords: 45/23; 59/57; 59/78; 692/4022/1585; 692/4025/2021; Adolescent; Adult; Aged; Angiomyolipoma; Angiomyolipoma - drug therapy; Angiomyolipoma - genetics; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - adverse effects; China; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Everolimus - administration & dosage; Everolimus - adverse effects; Female; Frequency distribution; Genetic screening; Humanities and Social Sciences; Humans; Inhibitor drugs; Kidney Neoplasms - drug therapy; Kidney Neoplasms - genetics; Kidneys; Male; Middle Aged; multidisciplinary; Mutation; Mutation Rate; Mutation rates; Patients; Science; Science (multidisciplinary); Short term; Statistical analysis; Targeted cancer therapy; Treatment Outcome; TSC1 gene; TSC2 gene; Tuberous sclerosis; Tuberous Sclerosis - complications; Tuberous Sclerosis - genetics; Tumor Burden - drug effects; Young Adult; China